448 related articles for article (PubMed ID: 18044787)
1. Effect of body mass index on the survival benefit of liver transplantation.
Pelletier SJ; Schaubel DE; Wei G; Englesbe MJ; Punch JD; Wolfe RA; Port FK; Merion RM
Liver Transpl; 2007 Dec; 13(12):1678-83. PubMed ID: 18044787
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit of kidney and liver transplantation for obese patients on the waiting list.
Pelletier SJ; Maraschio MA; Schaubel DE; Dykstra DM; Punch JD; Wolfe RA; Port FK; Merion RM
Clin Transpl; 2003; ():77-88. PubMed ID: 15387099
[TBL] [Abstract][Full Text] [Related]
3. Impact of recipient body mass index on organ allocation and mortality in orthotopic heart transplantation.
Weiss ES; Allen JG; Russell SD; Shah AS; Conte JV
J Heart Lung Transplant; 2009 Nov; 28(11):1150-7. PubMed ID: 19782581
[TBL] [Abstract][Full Text] [Related]
4. The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines?
Russo MJ; Hong KN; Davies RR; Chen JM; Mancini DM; Oz MC; Rose EA; Gelijns A; Naka Y
Ann Surg; 2010 Jan; 251(1):144-52. PubMed ID: 19940761
[TBL] [Abstract][Full Text] [Related]
5. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
[TBL] [Abstract][Full Text] [Related]
6. Prolonged waiting times for liver transplantation in obese patients.
Segev DL; Thompson RE; Locke JE; Simpkins CE; Thuluvath PJ; Montgomery RA; Maley WR
Ann Surg; 2008 Nov; 248(5):863-70. PubMed ID: 18948816
[TBL] [Abstract][Full Text] [Related]
7. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
Navarro WH; Loberiza FR; Bajorunaite R; van Besien K; Vose JM; Lazarus HM; Rizzo JD
Biol Blood Marrow Transplant; 2006 May; 12(5):541-51. PubMed ID: 16635789
[TBL] [Abstract][Full Text] [Related]
8. Is there any survival advantage of obesity in Southern European haemodialysis patients?
Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
[TBL] [Abstract][Full Text] [Related]
9. Discordant utility of ideal body weight and body mass index as predictors of mortality in lung transplant recipients.
Culver DA; Mazzone PJ; Khandwala F; Blazey HC; Decamp MM; Chapman JT;
J Heart Lung Transplant; 2005 Feb; 24(2):137-44. PubMed ID: 15701427
[TBL] [Abstract][Full Text] [Related]
10. Body mass index and enrollment on the renal transplant waiting list in the United States.
Abbott KC; Glanton CW; Agodoa LY
J Nephrol; 2003; 16(1):40-8. PubMed ID: 12649534
[TBL] [Abstract][Full Text] [Related]
11. The impact of wait list body mass index changes on the outcome after liver transplantation.
Orci LA; Majno PE; Berney T; Morel P; Mentha G; Toso C
Transpl Int; 2013 Feb; 26(2):170-6. PubMed ID: 23199077
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit after liver transplantation: a single European center experience.
Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD
Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783
[TBL] [Abstract][Full Text] [Related]
13. Greater travel time to a liver transplant center does not adversely affect clinical outcomes.
Firozvi AA; Lee CH; Hayashi PH
Liver Transpl; 2008 Jan; 14(1):18-24. PubMed ID: 18161800
[TBL] [Abstract][Full Text] [Related]
14. Pre-transplant obesity in heart transplantation: are there predictors of worse outcomes?
Macha M; Molina EJ; Franco M; Luyun L; Gaughan JP; McClurken JB; Furukawa S
Scand Cardiovasc J; 2009; 43(5):304-10. PubMed ID: 19291586
[TBL] [Abstract][Full Text] [Related]
15. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation at the extremes of the body mass index.
Dick AA; Spitzer AL; Seifert CF; Deckert A; Carithers RL; Reyes JD; Perkins JD
Liver Transpl; 2009 Aug; 15(8):968-77. PubMed ID: 19642131
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and outcome after ventricular assist device placement.
Musci M; Loforte A; Potapov EV; Krabatsch T; Weng Y; Pasic M; Hetzer R
Ann Thorac Surg; 2008 Oct; 86(4):1236-42. PubMed ID: 18805168
[TBL] [Abstract][Full Text] [Related]
18. Morbid obesity with one or more other serious comorbidities should be a contraindication for liver transplantation.
Thuluvath PJ
Liver Transpl; 2007 Dec; 13(12):1627-9. PubMed ID: 18044753
[No Abstract] [Full Text] [Related]
19. Morbid obesity is not a contraindication to kidney transplantation.
Marks WH; Florence LS; Chapman PH; Precht AF; Perkinson DT
Am J Surg; 2004 May; 187(5):635-8. PubMed ID: 15135681
[TBL] [Abstract][Full Text] [Related]
20. Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models.
Durand F; Belghiti J; Troisi R; Boillot O; Gadano A; Francoz C; de Hemptinne B; Mallet A; Valla D; Golmard JL
Liver Transpl; 2006 Feb; 12(2):231-9. PubMed ID: 16447208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
